In a recent study, we described a group of monoclonal antibodies that identify five high molecular mass proteins which associate with intermediate filaments 
Introduction
LMP1 is one of the three virally encoded membrane proteins expressed in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs). LMP1 is essential for B cell transformation (Kaye et al., 1993) . It appears approximately 40 h after entry of the virus, with considerable delay after the expression of EBNA proteins (Allday et al., 1989 ; Alfieri et al., 1991) . EBNA2 expression is a prerequisite for LMP1 synthesis (Abbot et al., 1990 ; Fahraeus et al., 1990 a) .
LMP1 is an important mediator of the EBV-induced phenotypic changes that accompany the transformation of resting B cells into immunoblasts. Introduction of LMP1 into EBV-negative or EBV-positive type I Burkitt's lymphoma (BL) cell lines may induce a shift towards an LCL-like phenotype (Wang et al., 1988 b) . It has been shown to upregulate a variety Author for correspondence : Laszlo Szekely.
Fax j46 8 32 78 75. e-mail lassze!ki.se † Present address : INN Neuromed, 86077, Pozzilli, Italy. origin express these proteins regularly at high levels. They are preferentially but not exclusively associated with vimentin filaments in the cytoplasm. Here we show that all five pNDCFs can be upregulated by expressing the EBV-encoded membrane protein LMP1 in type I BLs. Three of them could also be upregulated in the human keratinocyte cell line RHEK-1 by LMP1 transfection. This upregulation was paralleled by the LMP1-induced increase in vimentin expression in both cell types. One of the pNDCFs, detected by the MAb DMI4A6, accumulated in cap-like structures under the cell membrane that colocalized with membrane patches of LMP1, in addition to its localization in nuclear dots and in association with cytoplasmic vimentin filaments.
of cellular proteins, including the adhesion molecules LFA-1, LFA-3 and ICAM-1 (Wang et al., 1988 b) , the insulin receptor (Kriauciunas et al., 1993) , activation markers CD21 and CD23 (Wang et al., 1990 ), bcl-2 (Henderson et al., 1991 , IL10 (Nakagomi et al., 1994) and vimentin (Birkenbach et al., 1989) . It also upregulates endogenous antigen processing in type I BL lines by increasing the expression of HLA class I and class II proteins and the peptide transporters Tap-1 and Tap-2 (Zhang et al., 1994 ; Rowe et al., 1995) .
LMP1 expression activates the NF-κB pathway (Hammarskjold & Simurda, 1992) by posttranslational modification of the negative regulator I-κB α (Herrero et al., 1995) . The cytoplasmic tail of LMP1 can interact with tumour necrosis factor receptor family-associated TRAF proteins, suggesting that LMP1 can trigger a constitutive signalling through the TNF receptor pathway (Mosialos et al., 1995) .
LMP1 transforms established rodent fibroblasts, manifested in the disruption of actin cables, reduced serum requirement and increased anchorage-independent growth. LMP1-transfected fibroblasts are more resistant to contact inhibition and can form tumours in nude mice (Wang et al., 1985) . LMP1- transfected cells of the simian virus 40 (SV40)-immortalized human RHEK-1 keratinocyte cell line show reduced differentiation and increased agarose clonability (Fahraeus et al., 1990 b) . Similar observations were made on an LMP1-transfected squamous cell carcinoma line as well (Dawson et al., 1990) . In EBV-transformed LCLs, LMP1 agglomerates in cap-like membrane patches, associated with vimentin filament aggregates (Liebowitz et al., 1986) . It was suggested that vimentin or vimentin-associated proteins may be involved in LMP1-induced phenotypic changes (Liebowitz et al., 1987) . It may be noted, however, that the vimentin-negative Daudi line responded to LMP1 transfection with LMP1-containing patch formation and the appearance of B cell activation markers (Liebowitz & Kieff, 1989) .
We have recently reported the generation of five monoclonal antibodies (designated DM 1B5, DM 4A6, DM 5C6, DM 6A2 and DM 10H2) that react with previously unidentified, high molecular mass ( 200 kDa) proteins that are induced in EBV-transformed and mitogen-activated (anti-CD40 and IL4) human B cells. These proteins were operationally designated pNDCFs (proteins associated with nuclear dots and cytoplasmic filaments). They are not expressed in phenotypically representative (type I) BL cells, or are only present at low levels, localized within the nucleus. In EBVimmortalized LCLs and in some of the LCL-like (type III) BL cell lines, the pNDCFs are expressed at a high level, preferentially associated with vimentin filaments in the cytoplasm (Szekely et al., 1997) .
In the present paper we show that pNDCF expression can be induced by LMP1 alone in transfected type I BLs and in epithelial cells as well.
Methods
Cells and cell culture. All cell lines were cultured at 37 mC, in Iscove's medium containing 10 % foetal calf serum and 50 µg\ml Gentamycin. Absence of mycoplasma contamination was monitored by periodic staining with Hoechst 33258. The following original cell lines and LMP1-transfected derivatives were used : BL41 Lenoir et al., 1985 ; Cuomo et al., 1992) , Rael (Klein et al., 1972 ; Cuomo et al., 1993) , DG75 (Ben-Bassat et al., 1977 ; Cuomo et al., 1990) , S6C (Kuzumaki et al., 1980 ; Trivedi et al., 1991 Trivedi et al., , 1994 and RHEK-1 (Fahraeus et al., 1990 b) .
Zinc-mediated induction of LMP1 from the metallothionein promoter was carried out as described by Cuomo et al. (1992) .
Immunofluorescence staining and image analysis. Immunofluorescence staining was performed as previously described (Szekely et al., 1991 (Szekely et al., , 1995 . Briefly, cells were regularly fixed with methanolacetone (1 : 1) for at least 10 min and rehydrated in PBS. The supernatants and ascites were diluted in blocking buffer (2 % BSA, 0n2 % Tween 20, 10 % glycerol, 0n05 % NaN $ in PBS) in the proportion of 1 : 1 and 1 : 50-1000, respectively, depending on the individual antibodies. The first antibody was incubated with the cells for 30 min at room temperature followed by three 2 min washes. The secondary antibody, FITCconjugated rabbit anti-mouse IgG (DAKOPATTS) was diluted in blocking buffer (1 : 20). Biotinylation of the vimentin antibody and double fluorescence staining was done as described (Jiang et al., 1991 ; Szekely et al., 1996) .
The slides were mounted with 70 % glycerol, 2n5 % DABCO (Sigma) pH 8n5 in PBS. Images were generated using a Leitz DM RB microscope, equipped with Leica PL Fluotar 100i, 40i and PL APO Ph 63i oil immersion objectives. Leica L4, Tx and A composite filter cubes were used for the FITC, Texas Red and Hoechst 33258 fluorescence, respectively. The pictures were captured with HAMAMATSU dual mode cooled CCD camera (C4880), recorded and analysed on a Pentium PC (133 MHz, 32 Mb RAM) computer equipped with an AFG VISIONplus-AT frame grabber board using the Hipic3.2.0 (HAMAMATSU), Image-Pro Plus (Media Cybernetics) and Adobe Photoshop image capturing and processing software.
Western blotting. Detection of membrane blotted proteins was carried out as described previously (Szekely et al., 1993) with the modification that chemoluminescence (ECL kit, Bio-Rad) was used to detect the peroxidase-conjugated sheep anti-mouse IgG.
Results

Increased expression of pNDCFs in LMP1-transfected BLs
BL41 is an EBV-negative BL cell line that expresses very low levels of vimentin and is completely negative for two (DM 5C6 and DM 6A2) of the five MAbs against the pNDCFs. The other three pNDCFs are expressed at low levels. The proteins detected by the MAbs DM 1B5 and DM 10H2 are exclusively in the nucleus, whereas MAb DM 4A6 detects a non-filamentous submembrane cap in addition to the nucleus. The in vitro EBV-converted subline BL41\95 that has switched to a more immunoblastic (type III) phenotype (Torsteinsdottir et al., 1989) showed increased expression of the pNDCFs and vimentin. Most of the pNDCFs were associated with cytoplasmic filaments in these cells, as in LCLs and some type III BLs (Szekely et al., 1997) .
We tested the expression of the pNDCFs by immunofluorescence in two LMP1-transfected clones of BL41, MTLM-5 and MTLM-11. They carry an LMP1 cDNA construct driven by a metallothionein promoter. These clones express LMP1 at a low but inducible level and high constitutive level, respectively. The clone MTLM-11 showed high pNDCF expression by both immunofluorescence staining (Fig. 1) Western blotting (Fig. 2 ) with all five antibodies, whereas MTLM-5 showed weak but detectable expression. LMP1-transfected DG75 cells also showed increased expression in comparison with the untransfected control. In order to exclude the possibility that the increased expression of the pNDCFs was an accidentally fixed collateral property of the transfected clones, rather than a direct consequence of the increased LMP1 expression, we induced the metallothionein promoter of the LMP1 construct in MTLM-5 cells by ZnCl # treatment for 5 days. The level of LMP1 expression was raised to the same level as in MTLM-11. The pNDCF levels increased in parallel, approaching the MTLM-11 level (Fig. 3) .
The vast majority of the pNDCFs were associated with intermediate filament (IF)-like structures in the cytoplasm of the high LMP1-expressing cells. Double immunofluorescence staining with α-pNDCFs and biotinylated anti-vimentin antibodies showed that the pNDCFs were associated with vimentin filaments. Most of the immunostained structures appeared as fine granules, adhering to the surface of vimentin bundles (Fig. 4 a) . Table 1 for description. Vimentin expression could also be related to LMP1 expression in the BL41 and DG75 clones. The parental cells expressed only small amounts of vimentin, which failed to form continuous cytoplasmic networks but was arranged into short non-branching bundles. High LMP1-expressing derivatives contained abundant cytoplasmic vimentin networks.
CADG
To examine whether vimentin expression was a prerequisite for LMP1-induced pNDCF expression we tested type I BL cells of the Rael line, which does not express vimentin, LMP1 or pNDCFs. Introduction of LMP1 by retrovirus-mediated gene transfer failed to induce vimentin in two independent clones, but it induced pNDCFs. They were localized to randomly distributed cytoplasmic dots and were not associated with filamentous structures (Fig. 5) .
Previously we noticed that one of the MAbs, DM 4A6, detects submembrane patches in addition to nuclear dots and cytoplasmic filaments in different LCLs and BLs. The size and distribution of these patches were very similar to the membrane caps detected by the anti-LMP1 antibody. Double immunofluorescence staining of pNDCF% A' and LMP1 in LCL IARC171 showed considerable overlap between the two patches, although the distribution of the two proteins within the patch was different at high resolution (Fig. 4 b) .
Effect of LMP1 on the expression of pNDCFs in the RHEK-1 human keratinocyte line
To examine whether LMP1 could induce pNDCFs in non-B cells, we compared the expression of the five proteins in an SV40-immortalized human keratinocyte cell line, RHEK-1, and its LMP1-transformed derivative (Fig. 6) .
All five MAbs stained a fraction of the parental cells.
Cytoplasmic IF-like filamentous structures were stained predominantly, together with some distinct nuclear foci. DM 5C6 stained less than 1 % of the cells scattered randomly among the negative cells. The other four MAbs (DM 1B5, DM 4A6, DM 6A2 and DM 10H2) stained well circumscribed islands of positive cells that ranged from 10 % to 30 %. DM 1B5 gave a particularly intense staining of cytoplasmic filaments in mitotic cells that were not related to the mitotic spindle. Only a very small proportion ( 1 %) of the parental RHEK-1 cells expressed vimentin. Double immunofluorescence staining for vimentin and pNDCFs showed that the DM 5C6-positive cells were also vimentin-positive, whereas the cells stained by the other four MAbs were not. LMP1-transfected RHEK-1 cells showed a dramatic increase in vimentin expression. One hundred percent of the cells showed strong filamentous cytoplasmic staining. Three of the five α-pNDCFs (DM 5C6, DM 6A2 and DM 10H2) showed strong cytoplasmic filamentous staining in all cells. Antibodies DM 1B5 and DM 4A6 showed no increased staining compared to the control cells.
LMP1 induces changes in the subcellular distribution of pNDCFs in mouse mammary carcinoma cells
Recently we have shown that all five anti-PNDCF MAbs were able to react with the corresponding mouse proteins. The staining patterns in SCID mouse embryos were individually distinct for the five antibodies (Szekely et al., 1997) . We wanted to test whether the pattern can be changed by LMP1. We chose a mouse mammary carcinoma cell line (S6C) for LMP1 transfection.
We found that S6C cells expressed all five pNDCFs in a K. Pokrovskaja and others K. Pokrovskaja and others relatively low and individually distinct pattern for each protein.
LMP1 expression changed the subcellular distribution of all five proteins (Table 1 and Fig. 7) . As a rule LMP1 inhibited the nuclear accumulation of the pNDCFs, and increased the association with IF-like cytoplasmic filaments. In those cases when the parental cells showed an evenly distributed cytoplasmic filamentous pattern for a given pNDCF, the LMP1-transfected derivatives exhibited a striking polarization by accumulating the particular pNDCFs along a few major filament bundles, regularly only on one side of the nucleus.
Discussion
Using a set of MAbs directed against nucleoskeletonenriched cellular fraction, we have previously identified a group of high molecular mass proteins, designated pNDCFs (proteins associated with nuclear dots and cytoplasmic filaments) that are abundant in EBV-transformed LCLs and in in vitro-propagated BL cell lines that have shifted to a more immunoblastic phenotype, but not in BL cell lines or resting B cells. Since the EBV-encoded major membrane protein LMP1 can induce many of the phenotypic traits associated with the virally transformed immunoblast, we have examined its effect on EBV-negative BLs and on a human keratinocyte line. We found that the pNDCFs were induced in both cell types. Moreover, LMP1 induced major changes in the subcellular distribution of the pNDCFs in transfected murine mammary carcinoma cells. In these latter cells pNDCFs can be present both in the nucleus and in the cytoplasm. Following LMP1 transfection they disappear from the nucleus and accumulate in the cytoplasm where most of them are closely associated with IFs.
Many of the LMP1 effects on the cellular phenotype may be related to its ability to mimic TNF receptor-mediated signalling by complexing with TRAFs (Mosialos et al., 1995) . In B cells LMP1 may constitutively activate the CD40-mediated signal transduction pathway. We have previously shown that treatment of human peripheral blood B lymphocytes with anti-CD40 antibodies and IL4 leads to a strong increase in pNDCF expression (Szekely et al., 1997) . An LMP1-mediated increase in pNDCF expression is therefore consistent with the activation of the CD40 pathway.
LMP1 tends to form cap-like patches in the membrane of infected B cells. It is therefore of interest that one of the pNDCFs (recognized by MAb DM 4A6) that associates with IFs and nuclear foci, like other proteins of the group, accumulates in membrane patches as well. They overlap with the LMP1 caps to a large extent.
LMP1 induces vimentin both in BL and RHEK-1 cells. As shown in this paper this is paralleled by the induction of vimentin-associated pNDCFs. However, the induction of pNDCFs is not dependent on the presence of vimentin. Cells of the type I BL cell line Rael do not express vimentin and cannot be induced to do so by LMP1 transfection. Nevertheless, LMP1 induced pNDCFs in Rael cells. In vimentinnegative cells pNDCFs were not associated with cytoplasmic filaments, but scattered randomly throughout the cytoplasm. It may be relevant in this context that LMP1-transfected Rael cells maintain their BL phenotype after LMP1 transfection and fail to upregulate most of their activation markers, with the exception of ICAM-1 (Cuomo et al., 1993) , CD21 and CD40 (Rowe et al., 1994) . The induction of pNDCFs in these cells by LMP1 therefore suggests that it is not a secondary consequence of the overall phenotypic change, but a relatively direct effect of LMP1. Transfection of LMP1 into Rael cells activates NF-κB (Rowe et al., 1994) . This raises the possibility that NF-κB might be involved in the induction of pNDCFs.
LMP1 inhibits the differentiation of the human squamous cell carcinoma-derived cell line SSC12 (Dawson et al., 1990) . LMP1 expression in RHEK-1 cells causes multiple phenotypic changes. The cobblestone-like monolayers of the parental keratinocytes are frequently disrupted. The cells become more fibroblast-like, grow in disorganized and partly multilayered bundles and are less compact and more scattered on the periphery of the colony. These changes are accompanied by the downregulation of cytokeratins (Fahraeus et al., 1990 b) , Ecadherins (Fahraeus et al., 1992) , epithelial membrane antigen and epithelial glycoprotein,and the upregulation of lymphocyte activation-associated antigen CDw70 (Niedobitek et al., 1992) . LMP1-transfected RHEK-1 cells show an increased capacity to migrate into collagen gels (Fahraeus et al., 1992) , are more clonable in soft agar and have a decreased serum requirement (Hu et al., 1993) . The upregulation of vimentin and three of the five pNDCFs, shown in the present study, may be related to these changes.
Expression of LMP1 in established rodent fibroblasts leads to several phenotypic changes. It transforms NIH3T3 and Rat-1 cells while disrupting the monolayers into more disorganized and less contact-inhibited cultures after having disrupted the organization of actin cables. LMP1 reduces the serum requirement of transfected cells and promotes their anchorageindependent growth. LMP1-transfected cells are more resistant to contact inhibition, and can form tumours in nude mice (Wang et al., 1985) .
Targeted expression of LMP1 in the epidermis of transgenic mice leads to the development of a lethal hyperplastic dermatosis with the concomitant upregulation of the hyperproliferation-associated keratin 6 subtype that appears in aberrant locations (Wilson et al., 1990) . In SHG murine mammary carcinoma cells, transfected LMP1 downregulates Ecadherin and increases the capacity of the cells to invade collagen gels (Fahraeus et al., 1992) . We tested a similar mouse tumour virus-induced mammary carcinoma cell line, S6C, for the effect of LMP1 on pNDCF expression. LMP1 induced major rearrangements in the subcellular distribution of the pNDCFs. It increased the association of the proteins with asymmetrically distributed cytoplasmic IF-like filaments and inhibited their accumulation in the nucleus.
CADI
LMP1 protein is expressed in only 65 % of the EBVcarrying nasopharyngeal carcinomas in vivo (Fahraeus et al., 1988 ; Brooks et al., 1992) . Comparison of expressors with nonexpressors with regard to pNDCFs is now of obvious interest, as is an examination of other LMP1-expressing, EBV-carrying malignancies such as Hodgkin's lymphomas and immunoblastic lymphomas.
